FINANCIALS

SPRO Spero Therapeutics Inc 1701108

Income Statement
Revenue	spro-20240930	65,000
Net Income	spro-20240930	-17,900,000
Profit Margin		-27538.46%

Balance Sheet
Current Assets	131,627,000
Assets	135,161,000
Current Liabilities	49,096,000
Liabilities	69,654,000
Equity	65,507,000
Shares Out	54,049,000

Cash Flow Statement
Operating Cash Flow	-43,000

Market Analysis
Market Cap	72,966,326
Price	0.91
BVPS	1.21
PB	0.75
EPS	0.32
PE	4.26
PS	280.64

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view SPRO documents filed with the SEC.

SPRO Filings Clear

View A List of Tickers